Literature DB >> 12657530

Autoimmunity to nucleosomes related to viral infection: a focus on hapten-carrier complex formation.

Marijke Van Ghelue1, Ugo Moens, Signy Bendiksen, Ole Petter Rekvig.   

Abstract

Systemic lupus erythematosus (SLE) is an autoimmune disorder with unknown aetiology. The major hallmark of this disease is the presence of antibodies against nuclear components, including double-stranded (ds)DNA and histones. The disease affects different organs, particularly the skin, kidneys and the nervous system. Although the exact molecular mechanisms underlying the pathophysiological processes in SLE remain unknown, several inherent and environmental factors seem to be involved in the ethiopathogenesis of this disorder. Viruses may be one of the factors that induce the production of autoreactive antibodies although the involved mechanisms are still incompletely understood. One proposed mechanism for virus-induced production of autoantibodies is molecular mimicry. Another mechanism derives from studies with the human polyomavirus BK. In these studies, in vivo binding of the polyomaviruses large T-antigen to chromatin of infected cells may render chromatin immunogenic. The large T-antigen-chromatin complex may thus function as a hapten-carrier model with subsequent production of anti-chromatin antibodies, including anti-dsDNA and anti-histones antibodies. This review focuses on the recent findings suggesting that this model may be applicable for other human viruses associated with SLE.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12657530     DOI: 10.1016/s0896-8411(02)00110-5

Source DB:  PubMed          Journal:  J Autoimmun        ISSN: 0896-8411            Impact factor:   7.094


  16 in total

Review 1.  Structure-immunogenicity relationships of therapeutic proteins.

Authors:  Suzanne Hermeling; Daan J A Crommelin; Huub Schellekens; Wim Jiskoot
Journal:  Pharm Res       Date:  2004-06       Impact factor: 4.200

Review 2.  The pathogenesis and diagnosis of systemic lupus erythematosus: still not resolved.

Authors:  Ole Petter Rekvig; Johan Van der Vlag
Journal:  Semin Immunopathol       Date:  2014-04-25       Impact factor: 9.623

Review 3.  The anti-DNA antibody: origin and impact, dogmas and controversies.

Authors:  Ole P Rekvig
Journal:  Nat Rev Rheumatol       Date:  2015-06-02       Impact factor: 20.543

Review 4.  Vaccine-preventable infections in Systemic Lupus Erythematosus.

Authors:  Giuseppe Murdaca; Andrea Orsi; Francesca Spanò; Valeria Faccio; Francesco Puppo; Paolo Durando; Giancarlo Icardi; Filippo Ansaldi
Journal:  Hum Vaccin Immunother       Date:  2016-03-03       Impact factor: 3.452

Review 5.  Infections and systemic lupus erythematosus.

Authors:  S Esposito; S Bosis; M Semino; D Rigante
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2014-04-09       Impact factor: 3.267

6.  Prevalence of the NKG2D Thr72Ala polymorphism in patients with systemic lupus erythematosus.

Authors:  Piotr Piotrowski; Margarita Lianeri; Marzena Olesińska; Paweł P Jagodziński
Journal:  Mol Biol Rep       Date:  2011-05-20       Impact factor: 2.316

7.  Evidence for intranasal antinuclear autoantibodies in patients with chronic rhinosinusitis with nasal polyps.

Authors:  Bruce K Tan; Quan-Zhen Li; Lydia Suh; Atsushi Kato; David B Conley; Rakesh K Chandra; Jinchun Zhou; James Norton; Roderick Carter; Monique Hinchcliff; Kathleen Harris; Anju Peters; Leslie C Grammer; Robert C Kern; Chandra Mohan; Robert P Schleimer
Journal:  J Allergy Clin Immunol       Date:  2011-10-13       Impact factor: 10.793

Review 8.  Anti-dsDNA antibodies as a classification criterion and a diagnostic marker for systemic lupus erythematosus: critical remarks.

Authors:  O P Rekvig
Journal:  Clin Exp Immunol       Date:  2015-01       Impact factor: 4.330

9.  Parasites or cohabitants: cruel omnipresent usurpers or creative "éminences grises"?

Authors:  Marcos A Vannier-Santos; Henrique L Lenzi
Journal:  J Parasitol Res       Date:  2011-07-18

10.  Clinical phenotype associations with various types of anti-dsDNA antibodies in patients with recent onset of rheumatic symptoms. Results from a multicentre observational study.

Authors:  Michele Compagno; Ole P Rekvig; Anders A Bengtsson; Gunnar Sturfelt; Niels H H Heegaard; Andreas Jönsen; Rasmus Sleimann Jacobsen; Gro Ø Eilertsen; Christopher G Fenton; Lennart Truedsson; Johannes C Nossent; Søren Jacobsen
Journal:  Lupus Sci Med       Date:  2014-04-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.